316 related articles for article (PubMed ID: 31360033)
21. Innovation in direct intrahepatic portosystemic shunt; a developing country experience.
Tahir MM; Ali M; Kamani L; Shaikh T; Siddiqui DK; Mustafa K
J Pak Med Assoc; 2023 Mar; 73(3):684-686. PubMed ID: 36932783
[TBL] [Abstract][Full Text] [Related]
22. Budd-Chiari syndrome/hepatic venous outflow tract obstruction.
Valla DC
Hepatol Int; 2018 Feb; 12(Suppl 1):168-180. PubMed ID: 28685257
[TBL] [Abstract][Full Text] [Related]
23. Portal vein aneurysm associated with Budd-Chiari syndrome treated with transjugular intrahepatic portosystemic shunt: a case report.
Tsauo J; Li X
World J Gastroenterol; 2015 Mar; 21(9):2858-61. PubMed ID: 25759562
[TBL] [Abstract][Full Text] [Related]
24. Transjugular intrahepatic portosystemic shunt in combination with oral anticoagulant for Budd-Chiari syndrome.
Seki S; Sakaguchi H; Kobayashi S; Kitada T; Nakamura K; Yamada R
Hepatogastroenterology; 2001; 48(41):1447-9. PubMed ID: 11677983
[TBL] [Abstract][Full Text] [Related]
25. Imaging and interventions in Budd-Chiari syndrome.
Mukund A; Gamanagatti S
World J Radiol; 2011 Jul; 3(7):169-77. PubMed ID: 21860712
[TBL] [Abstract][Full Text] [Related]
26. Update on the classification, assessment of prognosis and therapy of Budd-Chiari syndrome.
Senzolo M; Cholongitas EC; Patch D; Burroughs AK
Nat Clin Pract Gastroenterol Hepatol; 2005 Apr; 2(4):182-90. PubMed ID: 16265183
[TBL] [Abstract][Full Text] [Related]
27. Review article: a multidisciplinary approach to the diagnosis and management of Budd-Chiari syndrome.
Khan F; Armstrong MJ; Mehrzad H; Chen F; Neil D; Brown R; Cain O; Tripathi D
Aliment Pharmacol Ther; 2019 Apr; 49(7):840-863. PubMed ID: 30828850
[TBL] [Abstract][Full Text] [Related]
28. Budd-Chiari syndrome: Focus on surgical treatment.
Hidaka M; Eguchi S
Hepatol Res; 2017 Feb; 47(2):142-148. PubMed ID: 27249222
[TBL] [Abstract][Full Text] [Related]
29. Long Term Survival of Patients Undergoing TIPS in Budd-Chiari Syndrome.
Sonavane AD; Amarapurkar DN; Rathod KR; Punamiya SJ
J Clin Exp Hepatol; 2019; 9(1):56-61. PubMed ID: 30765940
[TBL] [Abstract][Full Text] [Related]
30. Nuclear medicine dynamic investigations in the diagnosis of Budd-Chiari syndrome.
Dragoteanu M; Balea IA; Piglesan CD
World J Hepatol; 2014 Apr; 6(4):251-62. PubMed ID: 24799994
[TBL] [Abstract][Full Text] [Related]
31. Noncirrhotic portal hypertension.
Rajekar H; Vasishta RK; Chawla YK; Dhiman RK
J Clin Exp Hepatol; 2011 Sep; 1(2):94-108. PubMed ID: 25755321
[TBL] [Abstract][Full Text] [Related]
32. Early experience of Budd-Chiari syndrome treatment with transjugular intrahepatic portosystemic shunt.
López-Méndez E; Chávez-Tapia NC; Avila-Escobedo L; Cabrera-Aleksandrova T; Uribe M
Ann Hepatol; 2006; 5(3):157-60. PubMed ID: 17060871
[TBL] [Abstract][Full Text] [Related]
33. Endovascular treatment of Budd-Chiari syndrome: Single center experience.
Rathod K; Deshmukh H; Shukla A; Popat B; Pandey A; Gupte A; Gupta DK; Bhatia SJ
J Gastroenterol Hepatol; 2017 Jan; 32(1):237-243. PubMed ID: 27218672
[TBL] [Abstract][Full Text] [Related]
34. Good clinical outcomes following transjugular intrahepatic portosystemic stent-shunts in Budd-Chiari syndrome.
Tripathi D; Macnicholas R; Kothari C; Sunderraj L; Al-Hilou H; Rangarajan B; Chen F; Mangat K; Elias E; Olliff S
Aliment Pharmacol Ther; 2014 Apr; 39(8):864-72. PubMed ID: 24611957
[TBL] [Abstract][Full Text] [Related]
35. Budd-Chiari syndrome and acute portal vein thrombosis: management by a transjugular intrahepatic portosystemic shunt (TIPS) and portal vein interventions via a TIPS.
Kori I; Bar-Zohar D; Carmiel-Haggai M; Samuels D; Nakache R; Oren R; Kessler A; Szold O; Ben-Haim M
J Gastrointest Surg; 2006 Mar; 10(3):417-21. PubMed ID: 16504889
[TBL] [Abstract][Full Text] [Related]
36. Acute Portal Vein Thrombosis, No Longer a Contraindication for Transjugular Intrahepatic Porto-Systemic Shunt (TIPS) Insertion.
Mammen S; Keshava SN; Kattiparambil S
J Clin Exp Hepatol; 2015 Sep; 5(3):259-61. PubMed ID: 26628844
[TBL] [Abstract][Full Text] [Related]
37. Anatomic Recanalization of Hepatic Vein and Inferior Vena Cava versus Direct Intrahepatic Portosystemic Shunt Creation in Budd-Chiari Syndrome: Overall Outcome and Midterm Transplant-Free Survival.
Mukund A; Mittal K; Mondal A; Sarin SK
J Vasc Interv Radiol; 2018 Jun; 29(6):790-799. PubMed ID: 29705227
[TBL] [Abstract][Full Text] [Related]
38. Transjugular intrahepatic portosystemic shunt by direct transcaval approach in patients with acute and hyperacute Budd-Chiari syndrome.
Gasparini D; Del Forno M; Sponza M; Branca B; Toniutto P; Marzio A; Pirisi M
Eur J Gastroenterol Hepatol; 2002 May; 14(5):567-71. PubMed ID: 11984158
[TBL] [Abstract][Full Text] [Related]
39. Changing spectrum of Budd-Chiari syndrome in India with special reference to non-surgical treatment.
Amarapurkar DN; Punamiya SJ; Patel ND
World J Gastroenterol; 2008 Jan; 14(2):278-85. PubMed ID: 18186568
[TBL] [Abstract][Full Text] [Related]
40. Transjugular intrahepatic portosystemic shunt creation using a three-dimensional fluoroscopy guidance system in patients with the Budd-Chiari syndrome.
Bell BM; Cura M; Shaw CJ; Rees CR
Proc (Bayl Univ Med Cent); 2015 Oct; 28(4):484-7. PubMed ID: 26424949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
